Latest news with #Russell3000Index
Business Insider
17 hours ago
- Business
- Business Insider
Xenon Pharmaceuticals joins Russell 3000, Russell 2000 Indexes
Xenon Pharmaceuticals (XENE) announced that the company has been added to the broad-market Russell 3000 and small-cap Russell 2000 Indexes as part of the annual reconstitution, effective at the close of U.S. equity markets on Friday, June 27, 2025. The Russell 3000 Index is an equity index that tracks the performance of the largest 3,000 U.S. stocks by market capitalization. The Russell 2000 Index measures the performance of the 2,000 smallest companies within the Russell 3000 Index. Inclusion in the Russell 2000 results in automatic inclusion in the appropriate growth and value style indexes. Russell U.S. Indexes are widely used by investment managers and institutional investors as the basis for index funds and as benchmarks for investment strategies. Approximately $10.6T in assets are benchmarked against Russell U.S. indexes.
Business Insider
4 days ago
- Business
- Business Insider
Envela added to membership of US small-cap Russell 2000 Index
Envela (ELA) Corporation was added as a member of the US small-cap Russell 2000 Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. Membership, based on inclusion in the Russell 3000 Index, remains for one year. CFO John DeLuca stated the inclusion reflects the company's performance and will elevate visibility with institutional investors. Confident Investing Starts Here:
Business Wire
4 days ago
- Business
- Business Wire
DiaMedica Therapeutics Announces Inclusion in the Russell 2000 ® and Russell 3000 ® Indexes
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, today announced its upcoming addition as a member of the US small-cap Russell 2000 and Russell 3000 Indexes, effective after the U.S. market closes on June 27. The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization, representing approximately 98% of the investable U.S. equity market. The Russell 2000 Index is a subset of the Russell 3000, measuring the performance of the small-cap segment. These indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. 'DiaMedica's inclusion in the Russell 2000 and Russell 3000 indexes marks an important milestone in our company's journey,' said Rick Pauls, President and CEO of DiaMedica. 'This recognition enhances our visibility among the broader investment community, supports increased institutional interest and ownership in our stock and serves as strong validation of our team's ability drive value for our shareholders.' DM199 for Preeclampsia KOL Replay DiaMedica also recently hosted a preeclampsia webinar featuring Prof. Baha Sibai, MD (University of Texas) Prof. Stephen Tong, MD, PhD (The University of Melbourne), Prof. Susan Walker, MD, PhD (The University of Melbourne), and who discussed the unmet need and current treatment landscape for preeclampsia (PE), a life-threatening pregnancy associated vascular disorder with no approved therapeutics. The Company plans to announce top-line Phase 2 results by mid-July. Click this link to listen to the replay About DiaMedica Therapeutics Inc. DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedica's lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases. For more information visit the Company's website at
Business Insider
5 days ago
- Business
- Business Insider
NioCorp to be added to Russell 3000 Index
NioCorp (NB) announced that it will be added as a member of the broad-market Russell 3000 Index, effective after the U.S. market opens on June 30 as part of the 2025 Russell indexes reconstitution. Confident Investing Starts Here:
Yahoo
12-06-2025
- Business
- Yahoo
Northland starts Venu Holding at Outperform, sees ‘attractive growth trajectory'
As previously reported, Northland initiated coverage of Venu Holding (VENU) with an Outperform rating and $15 price target Venu builds live music venues by collaborating and partnering with municipalities, notes the analyst, who believes the company is in the early innings of replicating its success after the successful launch of its flagship Ford Amphitheater. The firm sees an 'attractive growth trajectory' as the company plans to expand to 10 new markets over the next five years and likes the structuring of Venu's financing for new developments, the analyst tells investors. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on VENU: Disclaimer & DisclosureReport an Issue Venu Holding initiated with an Outperform at Northland Venu Holding Partners with Aramark for Exclusive Services Venu Holding announces 'fan-forward' preferred offering with 8% dividend Venu Holding, Aramark Sports + Entertainment enter strategic partnership Venu Holding to join Russell 3000 Index Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
